<DOC>
	<DOCNO>NCT01015547</DOCNO>
	<brief_summary>The objective study compare early polyarticular juvenile idiopathic arthritis ( JIA ) efficacy , safety , cost-benefit-ratio three treatment strategy : biologic combination , combination conventional disease-modifying drug ( DMARDs ) , methotrexate alone .</brief_summary>
	<brief_title>Aggressive Combination Drug Therapy Very Early Polyarticular Juvenile Idiopathic Arthritis</brief_title>
	<detailed_description>DMARD-naive polyarticular JIA patient early disease ( onset less 6 month ) randomize one three treatment strategy : ( 1 ) biological combination , i.e. , anti-TNF therapy infliximab plus methotrexate ; ( 2 ) Combination DMARDs methotrexate , sulfasalazine , plus hydroxychloroquine ; ( 3 ) Methotrexate alone . The efficacy evaluate American College Rheumatology Pediatric ( ACR Pedi ) criterion base 6 core set variable ( CSVs ) : 1. active joint ; 2. . joint pain tenderness limitation motion ; 3 . ESR ( mm/hr ) ; 4. Childhood Health Assessment Questionnaire ( CHAQ ) ; 5 . Physician 's Visual Analogue Scale ( VAS ) ; 6 . Patient/Parent VAS . To fulfill ACR Pedi 75 criterion , 3/6 CSVs improve 75 % 1/6 CSV worsen 30 % . All direct indirect cost document . The first phase study open-label clinical trial last 54 week . In second phase study patient follow 5 year , long-term outcome early aggressive therapy analyze . Serum , urine , saliva sample collect 3 5 year translational research .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>juvenile idiopathic arthritis arthritis last least 6 week 6 month polyarticular disease least 5 active joint least 3 joint pain tenderness limitation motion previous treatment DMARDs systemic JIA abnormality hematopoietic lymphatic system major concurrent medical condition inadequate psychosocial situation pregnancy nonabstinent female reproductive capacity without regular contraceptive use</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>juvenile idiopathic arthritis</keyword>
	<keyword>polyarthritis</keyword>
	<keyword>combination therapy</keyword>
	<keyword>biologic agent</keyword>
	<keyword>TNF antagonist</keyword>
	<keyword>infliximab</keyword>
</DOC>